And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...
Alzheimer's Researcher Faces Scrutiny Berislav Zlokovic, MD, PhD, a prominent Alzheimer's researcher and the head of a major ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
The onset of symptoms of Alzheimer's disease can occur and worsen faster in people that also have an alcohol use disorder ...
Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...
We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this ...
Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...
Medpage Today on MSN2d
Alzheimer's Data Withdrawn
A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...
A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...
The latest research strongly suggests that a medication that slows brain aging may ultimately be effective at treating ...
Together people affected by a disease that afflicts one in eight older adults in Florida, they came out to Jacksonville's ...